(Q37995638)

English

Safety of flecainide

scientific article published on April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Safety of flecainide (English)

1 reference

Europe PubMed Central

26 August 2017

3

object named as

Philippe Mabo

1 reference

Europe PubMed Central

26 August 2017

author name string

Juan Tamargo

1

1 reference

Europe PubMed Central

26 August 2017

Alessandro Capucci

2

1 reference

Europe PubMed Central

26 August 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

35

1 reference

Europe PubMed Central

26 August 2017

4

1 reference

Europe PubMed Central

26 August 2017

273-289

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.2165/11599950-000000000-00000

0 references

Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Drug therapy. Flecainide

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Effects of flecainide on ventricular function: clinical and experimental correlations.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide: safety and efficacy

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Safety of a controlled-release flecainide acetate formulation in the prevention of paroxysmal atrial fibrillation in outpatients

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Metabolism of flecainide

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

The influence of urinary pH on flecainide excretion and its serum pharmacokinetics

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide toxicity

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Efficacy of quinidine in high-risk patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Pharmacological cardioversion of atrial fibrillation: current management and treatment options

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Issues in the use of generic antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

A proposal for the clinical use of flecainide

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Proarrhythmia in patients treated for atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Pharmacokinetics of flecainide acetate in patients with severe renal impairment

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Hemodynamic effects of intravenous flecainide in acute noncomplicated myocardial infarction.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide-induced neuropathy

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Paranoid psychosis and myoclonus: flecainide toxicity in renal failure

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Oral flecainide pharmacokinetics in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Clinical course and outcome in class IC antiarrhythmic overdose

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

ECG findings in fatal flecainide intoxication.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide-induced sustained ventricular tachycardia successfully treated with lidocaine

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Amiodarone used in successful resuscitation after near-fatal flecainide overdose

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Antiarrhythmic agents: drug interactions of clinical significance

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide cardiotoxicity precipitated by electrolyte imbalance. Caution with thiazide diuretics

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Newer antidepressants and the cytochrome P450 system

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide in the intrauterine treatment of fetal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Fetal arrhythmia: prenatal diagnosis and perinatal management

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Influence of amiodarone on genetically determined drug metabolism in humans

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Flecainide: evidence of non-linear kinetics

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

https://api.crossref.org/works/10.2165%2F11599950-000000000-00000

21 January 2018

Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of an Abnormal Sinus Node to Intravenous Flecainide Acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and/or flutter monitored with trans-telephonic electrocardiography: a multicenter, placebo-controlled, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics and side effects of flecainide acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of flecainide with digoxin and propranolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracardiac adverse effects of flecainide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late proarrhythmia and understanding the time of occurrence of proarrhythmia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of flecainide on cardiac output

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic properties of flecainide acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral digoxin pharmacokinetics during multiple-dose flecainide treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertonic sodium bicarbonate in an acute flecainide overdose

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of flecainide safety in patients with supraventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral flecainide acetate for the treatment of ventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug-induced sodium channel blockade by sodium bicarbonate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using the right drug: a treatment algorithm for regular supraventricular tachycardias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biotransformation and elimination of 14C-flecainide acetate in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flecainide dose-response relations in stable ventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered pharmacokinetics of oral flecainide by cimetidine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of left ventricular dysfunction on flecainide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flecainide excretion in human breast milk

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22435343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11599950-000000000-00000

1 reference

Europe PubMed Central

26 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37995638&oldid=1997520761"